M1 Kliniken AGMKLNF 92 Pretax Margin % is 9.50% as of Dec. 2025, which is 11% above its 10-year median of 8.55. GuruFocus rates MKLNF with a GF Score™ of 92/100 and a GF Value™ of $9.85. The stock has 4 warning signs investors should review. Among 117 Medical Distribution companies, M1 Kliniken AG ranks better than 85.47% on this metric.
The historical rank and industry rank for M1 Kliniken AG's Pretax Margin % or its related term are showing as below:
MKLNF'
s Pretax Margin % Range Over the Past 10 Years
Min: 3.59 Med: 8.55 Max: 16.51
Current: 9.35
MKLNF's Pretax Margin % is ranked better than 85.47% of 117
companies
in the Medical Distribution industry
Industry Median: 2.37
vs MKLNF: 9.35
M1 Kliniken AG (OTCPK:MKLNF) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
M1 Kliniken AG Pretax Margin % Related Terms
M1 Kliniken AG Pretax Margin % Historical Data
* Premium members only.
The historical data trend for M1 Kliniken AG's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MKLNF vs MCK, COR, CAH: Pretax Margin % Comparison
For the Medical Distribution subindustry, M1 Kliniken AG's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
M1 Kliniken AG Pretax Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, M1 Kliniken AG's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where M1 Kliniken AG's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
M1 Kliniken AG (MKLNF) has a Pretax Margin % of 9.50% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on M1 Kliniken AG and its competitors. This is 11% above median its historical median of 8.55. Over the past decade, M1 Kliniken AG's Pretax Margin % has ranged from 3.59 to 16.51. According to the industry distribution chart, M1 Kliniken AG ranks #17 out of 117 companies in the Medical Distribution industry, placing it in the top 14.5%.
Is M1 Kliniken AG's Pretax Margin % too high?
M1 Kliniken AG's current Pretax Margin % of 9.50% is 11% above median its 10-year median of 8.55. Over the past 10 years, this metric has ranged from a low of 3.59 to a high of 16.51. The Medical Distribution industry median Pretax Margin % is 2.37. M1 Kliniken AG's value of 9.50% is 300.8% above this industry median. Based on the distribution chart, M1 Kliniken AG ranks #17 out of 117 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, M1 Kliniken AG has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does M1 Kliniken AG's Pretax Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, M1 Kliniken AG ranks #17 out of 117 companies for Pretax Margin %. This places M1 Kliniken AG in the top 15% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 2.37. M1 Kliniken AG's value of 9.50% is 300.8% above this benchmark. Historically, M1 Kliniken AG's own Pretax Margin % has ranged from 3.59 to 16.51 over the past decade. While the company's 10-year median is 8.55 vs. the industry median of 2.37, M1 Kliniken AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Distribution company?
The median Pretax Margin % among Medical Distribution companies is 2.37, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. M1 Kliniken AG's current Pretax Margin % of 9.50% is 300.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on M1 Kliniken AG and its competitors. For the Medical Distribution industry, the median Pretax Margin % is 2.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. M1 Kliniken AG's current Pretax Margin % is 9.50%, which is 11% above median its own 10-year median of 8.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M1 Kliniken AG stock overvalued right now?
M1 Kliniken AG (MKLNF) has a current Pretax Margin % of 9.50%. The stock's GF Value™ is $9.85, compared to a current price of $11.73 — trading 19.1% above its estimated fair value. The current Pretax Margin % is 9.50%, which is 11% above median its 10-year median of 8.55 and 300.8% above the Medical Distribution industry median of 2.37. M1 Kliniken AG's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For M1 Kliniken AG (MKLNF), the current Pretax Margin % is 9.50% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is M1 Kliniken AG (MKLNF) Overvalued in 2026?
Based on GuruFocus' analysis, M1 Kliniken AG stock appears to be overvalued.
The current stock price of $11.73 is trading 19.1% above its estimated GF Value™ of $9.85.
Key valuation signals for MKLNF:
Pretax Margin %: 9.50% (11% above median its 10-year median of 8.55)
GF Value™: $9.85 vs. price of $11.73 (19.1% above fair value)
Industry Position: 300.8% above the Medical Distribution median (#17 of 117)
No single metric tells the full story. See the MKLNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
M1 Kliniken AG operates in the growing market of aesthetic medicine and plastic surgery and provides aesthetic medical treatments in the self-pay segment. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical, and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. The majority of its revenue is derived from the Trade segment.
92GF Score
Get the complete analysis for MKLNF
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MKLNF has been successfully added to your 
